Actively Recruiting
Impact of Multimodal Analgesia and ERAS Protocol on Length of Hospital Stay After Laparoscopic Gynecological Surgeries: A Randomized Control Trial
Led by Aga Khan University · Updated on 2026-02-17
98
Participants Needed
1
Research Sites
13 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying the impact of multimodal analgesia with or without the Enhanced Recovery After Surgery (ERAS) protocol on the length of hospital stay in female patients undergoing elective laparoscopic gynecological surgeries. This Phase 4 randomized trial aims to better understand how these approaches affect recovery times after surgery. Participants receive either the ERAS protocol or a control treatment. The ERAS protocol involves specific preoperative steps such as carbohydrate drinks and medication before surgery, followed by intravenous lidocaine and fentanyl during the procedure. The control group receives standard preoperative fasting and a different pain medication during surgery. The study compares these two approaches to see how they influence hospital stay length and recovery. During the study, researchers will measure the length of hospital stay from recovery room arrival until 72 hours after surgery. They will also assess pain levels at several time points after surgery, track opioid use, and evaluate patient satisfaction one day post-operation. Participants are monitored closely throughout the hospital stay to collect data on recovery experience and medication use.
CONDITIONS
Brief Title
Impact of ERAS Protocol on Length of Hospital Stay After Laparoscopic Surgeries
Who Can Participate
Eligibility Criteria
You may qualify if you...
- ASA physical status I, II, and III
- Female patients scheduled for elective laparoscopic gynecological surgeries
- Age between 20 and 60 years
You will not qualify if you...
- Refusal to participate
- History of allergy or contraindication to study drugs
- Procedures converted to open surgery
- Diagnostic laparoscopic procedures
- History of severe anxiety or depression
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of surgery
Participants receive either the Enhanced Recovery After Surgery protocol or standard care during laparoscopic gynecological surgery.
1 surgery day visit
Duration - 72 hours post-surgery
Participants are monitored for recovery including pain scores and opioid use after surgery.
Multiple visits at 4, 8, 12, 24, 48, and 72 hours postoperatively
Trial Site Locations
Total: 1 location
1
Aga Khan University, Karachi, Pakistan
Karachi, Sindh, Pakistan
Actively Recruiting
Research Team
A
Ali Sarfraz Siddiqui, MBBS, MCPS, FCPS, FIPP, MHPE
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here